Your session is about to expire
← Back to Search
Stem Cell Therapy
Regenexx SD for Rotator Cuff Tears
N/A
Waitlist Available
Led By Christopher Centeno, MD
Research Sponsored by Regenexx, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3, 6, 12 and 24 months
Awards & highlights
Study Summary
This trial is comparing the improvement in shoulder outcomes from a stem cell injection to that of exercise therapy, to see which is more effective.
Eligible Conditions
- Rotator Cuff Tears
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3, 6, 12 and 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3, 6, 12 and 24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
DASH Score Change from Baseline
Secondary outcome measures
Incidence of Complications and Adverse Events
Incidence of re-injection and surgical revision
MRI evidence of tendon repair
+2 moreTrial Design
2Treatment groups
Active Control
Group I: Regenexx SDActive Control1 Intervention
Bone Marrow Aspirate Concentrate injected under imaging guidance into the area of the damaged tendon.
Group II: Exercise TherapyActive Control1 Intervention
Subjects will be instructed in a set of appropriate rotator cuff strengthening exercises and given an instructional hand-out to take home.
Find a Location
Who is running the clinical trial?
Regenexx, LLCLead Sponsor
14 Previous Clinical Trials
50,794 Total Patients Enrolled
Christopher Centeno, MDPrincipal InvestigatorCenteno-Schultz Clinic
12 Previous Clinical Trials
50,346 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger